Identification of a serum-based miRNA signature for response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy

BACKGROUND: Neoadjuvant chemotherapy (NAC) has become the standard of care for resectable esophageal squamous cell carcinoma (ESCC) which is one of the most lethal cancers, to improve resectability and prognosis. On this basis, to provide individually optimized therapy for ESCC, a minimally-invasive...

Descripción completa

Detalles Bibliográficos
Autores principales: Niwa, Yukiko, Yamada, Suguru, Sonohara, Fuminori, Kurimoto, Keisuke, Hayashi, Masamichi, Tashiro, Mitsuru, Iwata, Naoki, Kanda, Mitsuro, Tanaka, Chie, Kobayashi, Daisuke, Nakayama, Goro, Koike, Masahiko, Fujiwara, Michitaka, Kodera, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317218/
https://www.ncbi.nlm.nih.gov/pubmed/30602370
http://dx.doi.org/10.1186/s12967-018-1762-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317218/
https://www.ncbi.nlm.nih.gov/pubmed/30602370
http://dx.doi.org/10.1186/s12967-018-1762-6

Ejemplares similares